Skip to content
PubMed This is a summary of 4 peer-reviewed journal articles Updated
Cardiology

What Is the Risk of Atrial Fibrillation With RXLI?

At a Glance

Adult men with Recessive X-linked Ichthyosis (RXLI) caused by the Xp22.31 gene deletion have up to a 35% risk of developing atrial fibrillation. Because these irregular heart rhythms are often silent, experts recommend discussing baseline EKG screening with your doctor to prevent stroke.

While Recessive X-linked Ichthyosis (RXLI) is primarily known for how it affects the skin, staying on top of your long-term health means taking proactive care of your heart, too. Recent research has discovered a strong link between the genetic deletion that causes most cases of RXLI and an increased risk of developing abnormal heart rhythms, specifically atrial fibrillation (AFib) and atrial flutter [1]. Because these rhythm issues can be “silent” and cause no symptoms at first, experts recommend discussing your cardiac risk and whether a baseline electrocardiogram (EKG) is appropriate with your primary care doctor [1].

RXLI is most commonly caused by a missing STS gene (specifically a deletion in the Xp22.31 region of the X chromosome), which leads to a deficiency of the steroid sulfatase (STS) enzyme [2][3]. While this enzyme deficiency causes the characteristic scaly skin of RXLI, the STS enzyme is also naturally present in your heart tissue and blood vessels [1].

When the STS gene is deleted, it appears to affect how the heart’s electrical and structural systems function. Studies show that adult men with this specific genetic deletion have a substantially higher risk of developing atrial fibrillation or atrial flutter compared to men in the general population [1]. In fact, up to 35% of individuals carrying the Xp22.31 deletion may experience some form of abnormal heart rhythm [1].

(Note: If your RXLI is caused by a smaller, isolated gene mutation rather than a full Xp22.31 deletion, your risk profile may differ, making it important to discuss your specific genetic test results with your doctor).

The Danger of “Silent” AFib

Atrial fibrillation and atrial flutter are conditions where the upper chambers of the heart beat irregularly and often too fast [4]. While some people feel palpitations, fluttering, or shortness of breath, many men with RXLI have asymptomatic or “silent” episodes. These abnormal rhythms often come and go rapidly without you ever noticing them [1].

Even when you cannot feel it, AFib allows blood to pool and become sluggish in the heart, drastically increasing the risk of forming a blood clot. If a clot breaks loose, it can travel to the brain and cause a stroke [1]. Over time, untreated AFib can also weaken the heart muscle and contribute to heart failure. Understanding this “silent” risk is why early detection through medical screening is vital.

Partnering With Your Doctor for Monitoring

Because you cannot rely on feeling sick or having a racing heartbeat to know if you have AFib, routine medical screening is your best defense. Since a dermatologist likely diagnosed your RXLI, it is highly recommended to share this information with your primary care physician to coordinate your cardiovascular care.

While there are no formal, universal clinical guidelines yet specifying an exact age to begin screening for men with RXLI, research highlights that cardiovascular risks increase as men reach middle age [1]. Discussing a preventative strategy with your doctor in adulthood is key.

  • Catching it early: A simple, painless EKG (electrocardiogram) can detect irregular electrical activity in your heart, even if you feel perfectly healthy. However, because a single point-in-time EKG can easily miss an intermittent (paroxysmal) episode, your doctor might also suggest a wearable Holter monitor or certain smartwatch features to track your heart over a longer period.
  • Effective management: If an abnormal rhythm is detected, there are many effective medical interventions available to manage it and reduce your risk of complications [1]. Your doctor can prescribe blood thinners (anticoagulants) to significantly lower your stroke risk, or use medications and procedures to keep your heart rhythm steady.
  • Tracking associated risks: Interestingly, researchers have noted that Xp22.31 deletion carriers who experience heart rhythm issues sometimes also have a personal history of asthma, anemia, or gastrointestinal issues [1]. Sharing your full medical history with your primary care doctor helps them assess your overall health and determine the best monitoring schedule for you.

Common questions in this guide

Why does RXLI increase the risk of atrial fibrillation?
RXLI is typically caused by a deletion of the STS gene, which results in an enzyme deficiency. Because this enzyme is normally active in heart tissue and blood vessels, its absence can disrupt the heart's electrical system and lead to abnormal rhythms like atrial fibrillation.
What are the symptoms of atrial fibrillation in people with RXLI?
While some may feel a racing heart, fluttering chest, or shortness of breath, many men with RXLI experience "silent" episodes. This means the irregular heartbeats come and go without causing any noticeable symptoms, which is why proactive screening is so important.
Should I get my heart checked if I have Recessive X-linked Ichthyosis?
Yes, it is highly recommended that adults with RXLI share their genetic diagnosis with their primary care physician. Doctors often suggest a baseline EKG or a wearable Holter monitor to check for hidden heart rhythm issues.
How is atrial fibrillation treated if it is discovered?
If an irregular rhythm is found, doctors can prescribe blood thinners to drastically reduce your risk of stroke. There are also effective medications and procedures available to help keep your heart beating at a steady, normal pace.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my RXLI diagnosis and age, is it appropriate to do a baseline EKG today?
  2. 2.If my regular EKG is normal, how often should we repeat this screening, or should I consider a wearable heart monitor?
  3. 3.At what point should I be referred to a cardiologist for my preventative care?
  4. 4.Do you have my specific genetic test results on file to confirm if I have the Xp22.31 deletion?
  5. 5.How do my other health factors (like weight, blood pressure, or lifestyle) interact with my genetic risk for atrial fibrillation?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (4)
  1. 1

    Characterising heart rhythm abnormalities associated with Xp22.31 deletion.

    Wren G, Baker E, Underwood J, et al.

    Journal of medical genetics 2023; (60(7)):636-643 doi:10.1136/jmg-2022-108862.

    PMID: 36379544
  2. 2

    X-linked ichthyosis: Molecular findings in four pedigrees with inconspicuous clinical manifestations.

    Zhang M, Huang H, Lin N, et al.

    Journal of clinical laboratory analysis 2020; (34(5)):e23201 doi:10.1002/jcla.23201.

    PMID: 31944387
  3. 3

    [Genetic analysis of a rare case with Kallman syndrome and steroid sulfatase deficiency].

    Liu X, Bai N, Kong X

    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2016; (33(3)):349-52 doi:10.3760/cma.j.issn.1003-9406.2016.03.016.

    PMID: 27264819
  4. 4

    Association of typical atrial flutter and cavotricuspid isthmus ablation on clinical recurrence after cryoballoon ablation for atrial fibrillation.

    Jeong JH, Lee HS, Choi YY, et al.

    Frontiers in cardiovascular medicine 2023; (10()):1303635 doi:10.3389/fcvm.2023.1303635.

    PMID: 38162135

This page explains cardiovascular risks associated with RXLI for educational purposes only. Always consult your primary care doctor or cardiologist for personalized medical screening and advice.

Get notified when new evidence is published on Recessive X-linked ichthyosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.